Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/129162
Title: A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
Authors: Lye, W.C.
Wong, P.L.
van der Straaten, J.C.
Leong, S.O.
Lee, E.J. 
Issue Date: 1995
Citation: Lye, W.C.,Wong, P.L.,van der Straaten, J.C.,Leong, S.O.,Lee, E.J. (1995). A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 11 : 179-181. ScholarBank@NUS Repository.
Abstract: There is an increasing trend towards the use of aminoglycosides in a once-daily dose administration for the treatment of severe infections in nonrenal failure patients. The use of once-daily dose aminoglycoside therapy may be associated with a reduction in toxicity. We performed a prospective randomized study comparing once-daily versus multiple-dose gentamicin in the treatment of continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Seventy-three patients with 100 new episodes of peritonitis were enrolled in the study. At presentation of peritonitis, the patients were alternately assigned to receive either intraperitoneal gentamicin at a dose of 40 mg/2 L dialysate administered as a once-daily dose or gentamicin at a dose of 10mg/2 L dialysate administered 4 times per day. All patients also received intraperitoneal vancomycin at a dose of 1 g per week. There were no significant differences in the treatment success (88% vs 82%, p = NS) and relapse (18% vs 20%, p = NS) rates between the once-daily dose and multiple-dose groups. The mean trough serum gentamicin level was higher in the once-daily dose group compared to the multiple-dose group (0.75 +/- 0.72 vs 1.50 +/- 1.40 mg/L). In conclusion, gentamicin administered in a once-daily dose is as effective as multiple-dose administration in the treatment of CAPD peritonitis. The lower gentamicin level with once-daily dose administration may be associated with a reduction in aminoglycoside toxicity.
Source Title: Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
URI: http://scholarbank.nus.edu.sg/handle/10635/129162
ISSN: 11978554
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

6
checked on Mar 10, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.